Association between the PARP1 Val762Ala Polymorphism and Cancer Risk: Evidence from 43 Studies

• Rui-Xi Hua ,

  Contributed equally to this work with: Rui-Xi Hua, He-Ping Li, Yan-Bing Liang

  Affiliation Department of Oncology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China

  ⨯
• He-Ping Li ,

  Contributed equally to this work with: Rui-Xi Hua, He-Ping Li, Yan-Bing Liang

  Affiliation Department of Oncology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China

  ⨯
• Yan-Bing Liang ,

  Contributed equally to this work with: Rui-Xi Hua, He-Ping Li, Yan-Bing Liang

  Affiliation General Department of Internal Medicine, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China

  ⨯
• Jin-Hong Zhu,

  Affiliation Department of Molecular Epidemiology and Laboratory Medicine, The Affiliated Tumor Hospital of Harbin Medical University, Harbin, China

  ⨯
• Bing Zhang,

  Affiliation Department of Nuclear Medicine, the First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China

  ⨯
• Sheng Ye,

  Affiliation Department of Oncology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China

  ⨯
• Qiang-Sheng Dai,

  Affiliation Department of Oncology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China

  ⨯
• Shi-Qiu Xiong,

  Affiliation Department of Pathology, University of Cambridge, Cambridge, United Kingdom

  ⨯
• Yong Gu ,

  * E-mail: pea333@163.com (YG); sxz973@126.com (X-ZS)

  Affiliation Department of Thoracic Surgery, the First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China

  ⨯
• Xiang-Zhou Sun

  * E-mail: pea333@163.com (YG); sxz973@126.com (X-ZS)

  Affiliation Department of Urinary Surgery, the First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China

  ⨯